Expression of metallothionein and p53 antigens are correlated in oral squamous cell carcinoma

Anticancer Research

Volumn 29, Issue 4, 2009, Pages 1189-1194

  Cardoso, Sérgio Vitorino ^a   Silveira JÚNIOR, João Batista ^b   De Machado, Vinícius Carvalho ^b   De Paula, Alfredo Maurecio Batista ^c   Loyola, Adriano Mota ^a   De Aguiar, Maria Cássia Ferreira ^b  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Oral Diagnosis   (Brazil)

Author keywords

Immunohistochemistry; Metallothionein; Oral cancer; P53 protein; Prognosis

Indexed keywords

METALLOTHIONEIN; PROTEIN P53;

ADULT; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; METALLOTHIONEIN; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 64949100389     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Moore SR, Johnson NW, Pierce AM and Wilson DF: The epidemiology of tongue cancer: a review of global incidence. Oral Dis 6: 75-84, 2000.
2. Malone JP, Stephens JA, Grecula JC, Rhoades CA, Ghaheri BA and Schuller DE: Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer. Head Neck 26: 561-572, 2004.
3. Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, Wolf GT, Urba SG, Chepeha DB, Teknos TN, Eisbruch A, Tsien CI, Taylor JM, D'Silva NJ, Yang K, Kurnit DM, Bauer JA, Bradford CR and Carey TE: EGFR, pl6, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer. J Clin Oncol. 2008 May 12. [Epub ahead of print].
4. Romero-Isart N and Vasak M: Advances in the structure and chemistry of metallothioneins. J Inorg Biochem 88: 388-396, 2002.
5. Jasani LJ and Schmid KW: Significance of metallothionein in human tumours. Histopathology 31: 211-214, 1997.
6. Cardoso SV, Barbosa HM, Candellori IM, Loyola AM and Aguiar MC: Prognostic impact of metallothionein on oral squamous cell carcinoma. Virchows Arch 441: 174-178, 2002.
7. Chu G: Cellular responses to cisplatin. The roles of DNA- binding proteins and DNA repair. J Biol Chem 269: 787-790, 1994.
8. Cai L, Satoh M, Tohyama C and Cherian MG: Metallothionein in radiation exposure: its induction and protective role. Toxicology 132: 85-98, 1999.
9. 2+ release. Proc Natl Acad Sci USA 100: 13952- 13957,2003.
10. Jacob C, Maret W and Vallee BL: Control of zinc transfer between thionein, metallothionein, and zinc proteins. Proc Natl Acad Sci USA 95: 3489-3494, 1998.
11. Zhang S, Li J, Wang CC, and Tsou CL: Metal regulation of metallothionein participation in redox reactions. FEBS Lett 462: 383-386, 1999.
12. Maret W and Vallee BL: Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc Natl Acad Sci USA 95: 3478-3482, 1998.
13. Cherian MG, Jayasurya A and Bay BH: Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res 533: 201-209,2003.
14. Hoffmann TK, Sonkoly E, Hauser U, van Lierop A, Whiteside TL, Klussmann JP, Hafner D, Schuler P, Friebe-Hoffmann U, Scheckenbach K, Erjala K, Grenman R, Schipper J, Bier H and Balz V: Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma. Oral Oncol. 2008 in press. doi:10.1016/ j.oraloncology.2008.02.006.
15. Carlos de Vicente J, Junquera Gutiérrez LM, Zapatero AH, Fresno Forcelledo MF, Hernández-Vallejo G and López Arranz JS: Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases. Head Neck 26: 22-30, 2004.
16. Pande P, Soni S, Kaur J, Agarwal S, Mathur M, Sukla NK and Ralhan R: Prognostic factors in betel and tobacco related oral cancer. Oral Oncol 38: 491-499, 2002.
17. Chaves AC, Cherubini K, Herter N, Furian R, Santos DS, Squier C and Domann FE: Characterization of p53 gene mutations in a Brazilian population with oral squamous cell carcinomas. Int J Oncol 24: 295-303, 2004.
18. Yamazaki Y, Chiba I, Hirai A, Sugiura C, Notani K, Kashiwazaki H, Tei K, Totsuka Y and Fukuda H: Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma. Oral Oncol 39: 163-169,2003.
19. Kato S, Han SY, Liu W, Otsuka K, Shibata H, Kanamaru R and Ishioka C: Understanding the function-structure and function- mutation relationships of p53 tumor suppressor protein by high- resolution missense mutation analysis. Proc Natl Acad Sci USA 100: 8424-8429, 2003.
20. Meplan C, Richard MJ and Hainaut P: Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene 19: 5227-5236, 2000.
21. Butler JS and Loh SN: Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain. Biochemistry 42: 2396-2403, 2003.
22. Hainaut P and Milner J: A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53. Cancer Res 53: 1739-1742, 1993.
23. Vousden KH and Prives C: P53 and prognosis: new insights and further complexity. Cell 120: 7-10, 2005.
24. Ostrakhovitch EA, Olsson PE, Jiang S and Cherian MG: Interaction of metallothionein with tumor suppressor p53 protein. FEBS Lett 580: 1235-1238, 2006.
25. Ostrakhovitch EA, Olsson PE, von Hofsten J and Cherian MG: P53 mediated regulation of metallothionein transcription in breast cancer cells. J Cell Biochem 102: 1571-1583, 2007.
26. Goncharova EI and Rossman TG: A role for metallothionein and zinc in spontaneous mutagenesis. Cancer Res 54: 5318-5323, 1994.
27. Nylander K, Dabelsteen E and Hall PA: The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 29: 413-425, 2000.
28. Ayres M, Ayres Junior M, Ayres DL and Sntos AS: Bioestat 3.0: Aplicações estatisticas nas áreas das ciências biológicas e médicas (ed 3). Belém, Brazil, Sociedade Civil Mamirauá / MCT - CNPq / Conservation International, 2003 (in Portuguese).
29. Campos-Filho N and Franco EL: Microcomputer-assisted univariated survival data analysis using Kaplan-Meier life table estimators. Comput Methods Programs Biomed 27: 223-228, 1990.
30. Ioachim EE, Kitsiou E, Carassavoglou C, Stefanaki S and Agnantis NJ: Immunohistochemical localization of metallothionein in endometrial lesions. J Pathol 191: 269-273, 2000.
31. Joseph MG, Banerjee D, Kocha W, Feld R, Stitt LW and Cherian MG: Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome. Cancer 92: 836-842, 2001.
32. Bruewer M, Schmid KW, Krieglstein CF, Senninger N and Shuermann G: Metallothionein: early marker in the carcinogenesis of ulcerative colitis-associated colorectal carcinoma. World J Surg 26: 726-731, 2002.
33. Douglas-Jones AG, Navabi H, Morgan JM and JasaniB: Immunoreactive p53 and metallothionein expression in duct carcinoma in situ of the breast. No correlation. Virchows Arch 430: 373-379, 1997.
34. Ioachim E, Assimakopoulos D, Peschos D, ZissiA, Skevas A and Agnantis NJ: Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen. Pathol Res Pract 195: 809-814, 1999.
35. Pastuszewski W, Dziegiel P, Krecicki T, Podhorska-Okolow M, Ciesielska U, Gorzynska E and Zabel M: Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer. Anticancer Res 27: 335-342, 2007.
36. Fan LZ and Cherian MG: Potential role of p53 on metallothionein induction in human epithelial breast cancer cells. Br J Cancer 87: 1019-1026,2002.
37. Szelachowska J, Dziegiel P, Jelen-Krzeszewska J, Jelen M, Tarkowski R, Wlodarska I, Spytkowska B, Gisterek I, Matkowski R and Kornafel J: Prognostic significance of nuclear and cytoplasmic expression of metallothioneins as related to proliferative activity in squamous cell carcinomas of oral cavity. Histol Histopathol 23: 843-851, 2008.